MARTIN J TYLER 4
4 · DYNAVAX TECHNOLOGIES CORP · Filed Nov 19, 2012
Insider Transaction Report
Form 4
MARTIN J TYLER
VP Clinical Development & CMO
Transactions
- Exercise/Conversion
Common Stock
2012-11-16$1.58/sh+35,759$56,499→ 222,089 total - Exercise/Conversion
Stock Option
2012-11-16−35,759→ 576,125 totalExercise: $1.58Exp: 2020-02-18→ Common Stock (35,759 underlying)
Footnotes (3)
- [F1]On November 16, 2012, Mr. Martin exercised certain of his outstanding options for cash. No shares were sold in the market in connection with this exercise.
- [F2]This Stock Option was granted on February 19, 2010 with an expiration of February 18, 2020 and vested upon the completion of a performance goal.
- [F3]Not applicable.